0 Comments
0 Shares
834 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Inflammatory Bowel Disease Market Is Estimated To Witness High GrowthSWOT Analysis Strength: Inflammatory Bowel Disease Market has growing cases of Crohn's disease and ulcerative colitis globally. There is an increased focus on treatment innovation with ongoing research and development. Biologics and biosimilars have emerged as promising treatment options. Weakness: High costs associated with diagnosis and long term treatment of IBD poses a major challenge....0 Comments 0 Shares 860 Views 0 Reviews
- Inflammatory Bowel Disease Treatment Market Analysis, Size, Share, and Forecast 2031The Inflammatory Bowel Disease Treatment Market in 2023 is US$ 21.11 billion, and is expected to reach US$ 28.49 billion by 2031 at a CAGR of 3.82%. FutureWise Research published a report that analyzes Inflammatory Bowel Disease Treatment Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the...0 Comments 0 Shares 15 Views 0 Reviews
- Inflammatory Bowel Disease Treatment Market Research, Development Status, Emerging TechnologiesMarket Overview The inflammatory bowel disease treatment market is expected to reach USD 19,520 Million by 2030 at 5.50% CAGR during the forecast period 2022-2030. During the forecast period, the Inflammatory Bowel Disease Treatment Market Report is expected to grow at a CAGR of 5.50%. Over the next few years, the market is likely to increase because ulcerative disease...0 Comments 0 Shares 983 Views 0 Reviews
- Inflammatory Bowel Disease Treatment Market Research, Development Status, Emerging Technologies, RevenueMarket Overview The inflammatory bowel disease treatment market is expected to reach USD 19,520 Million by 2030 at 5.50% CAGR during the forecast period 2022-2030. During the forecast period, the Inflammatory Bowel Disease Treatment Market Report is expected to grow at a CAGR of 5.50%. Over the next few years, the market is likely to increase because ulcerative...0 Comments 0 Shares 1089 Views 0 Reviews
- Inflammatory Bowel Disease Treatment Market Research, Development Status, Emerging Technologies, Revenue and Key FindingsMarket Overview The inflammatory bowel disease treatment market is expected to reach USD 19,520 Million by 2030 at 5.50% CAGR during the forecast period 2022-2030. During the forecast period, the Inflammatory Bowel Disease Treatment Market Report is expected to grow at a CAGR of 5.50%. Over the next few years, the market is likely to increase because ulcerative disease and...0 Comments 0 Shares 1344 Views 0 Reviews
- Inflammatory Bowel Disease Treatment Market to Witness Significant GrowthSWOT Analysis Strength: Inflammatory bowel disease market comprises various treatment options such as aminosalicylates, corticosteroids and immunosuppressant drugs which helps in managing the symptoms. Also, the increasing research and development activities by major manufacturers are focusing on developing novel biologics and biosimilars which is likely to drive the market growth over the...0 Comments 0 Shares 705 Views 0 Reviews
- Inflammatory Bowel Disease Treatment Market Trends and Market Set For Rapid Growth with Great CAGR by Forecast 2030Market Overview The Inflammatory Bowel Disease Treatment Market Insights And Analysis by Drug Class (TNF Inhibitors, Aminosalicylates) Disease Indication (Ulcerative Colitis, Crohn’s Disease) Distribution Channel (Hospital Pharmacy), End-User (Hospitals & Clinics)—Forecast till 2030 During the forecast period, the Inflammatory Bowel Disease Treatment...0 Comments 0 Shares 952 Views 0 Reviews
- Sulfasalazine Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Inflammatory Bowel Disease and Rising Demand for Effective MedicationsThe Sulfasalazine Market is estimated to be valued at US$ 2.01 billion in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Sulfasalazine Market refers to the global market for the drug Sulfasalazine, which is primarily used to treat inflammatory bowel disease such as...0 Comments 0 Shares 980 Views 0 Reviews
- Unveiling the Inflammatory Bowel Disease Market: Navigating Treatment Frontiers and AdvancementsInflammatory Bowel Disease (IBD) is a formidable challenge in the realm of gastroenterology, affecting millions of individuals worldwide. The intricate interplay between genetics, immune response, and environmental factors has fueled an intense pursuit of effective treatments and management strategies. In this blog, we delve into the complexities of the Inflammatory Bowel Disease Market,...0 Comments 0 Shares 841 Views 0 Reviews
- Inflammatory Bowel Disease is Estimated to Witness High Growth Owing to Rising Awareness and Product LaunchesInflammatory bowel disease (IBD) refers to conditions that cause chronic inflammation to the gastrointestinal tract. The most common types of IBD are Crohn's disease and ulcerative colitis. Crohn's disease can affect any part of the gastrointestinal tract from mouth to anus, whereas ulcerative colitis affects only the large intestine and rectum. IBD drugs aim to induce and maintain remission by...0 Comments 0 Shares 778 Views 0 Reviews
- Inflammatory Colitis Drug Market Size, Share, Key Players, Growth Trend, and Forecast, 2028Developments in biosimilars, increasing prevalence rate of Inflammatory Colitis, and changing lifestyle have resulted in boosting the Inflammatory Colitis Drug market. The global inflammatory colitis drug market is forecast to reach USD 10.69 Billion by 2028, according to a new report by Reports and Data. Inflammatory colitis (UC) can be defined as an inflammatory...0 Comments 0 Shares 2225 Views 0 Reviews
- Remicade Biosimilars Market is Estimated to Witness High Growth Owing to Increased Use for the Treatment of Rheumatoid ArthritisRemicade is a biologic disease-modifying anti-rheumatic drug used for the treatment of various autoimmune diseases. It is primarily used for rheumatoid arthritis, Crohn's disease, ulcerative colitis. Remicade biosimilars offer effective treatment alternatives at lower costs. This has increased the use of Remicade biosimilars in recent years. The global Remicade biosimilars Market is estimated...0 Comments 0 Shares 770 Views 0 Reviews
More Results